Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Industry News

Medtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark Approval

April 16, 2018

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

News Industry News

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

May 04, 2016

News Industry News

Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation

May 02, 2016

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as first contrast agent for use with magnetic resonance angiography of supra-aortic arteries

May 02, 2016

News Industry News

Boston Scientific Receives U.S. FDA Approval For ImageReady™ MR-Conditional Pacing System

April 26, 2016

News Industry News

Boston Scientific Announces CE Mark For MRI Labeling Of Emblem™ S-ICD Systems

April 20, 2016

News Industry News

Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia

February 22, 2016

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

February 04, 2016

News Industry News

FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology

December 21, 2015

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

September 15, 2015

News Industry News

Medtronic Announces Expansion of MR-Conditional Products with U.S. Launch of Advisa SR MRI(TM) SureScan® Pacing System

June 25, 2015

Advertisement

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Medtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark Approval

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation

FDA approves Bayer's Gadavist® (gadobutrol) injection as first contrast agent for use with magnetic resonance angiography of supra-aortic arteries

Boston Scientific Receives U.S. FDA Approval For ImageReady™ MR-Conditional Pacing System

Boston Scientific Announces CE Mark For MRI Labeling Of Emblem™ S-ICD Systems

Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

Medtronic Announces Expansion of MR-Conditional Products with U.S. Launch of Advisa SR MRI(TM) SureScan® Pacing System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content